Art

J-GLOBAL ID：201902274141543690   Reference number：19A0217253

Dietary Intake during 56 Weeks of a Low-Fat Diet for Lomitapide Treatment in Japanese Patients with Homozygous Familial Hypercholesterolemia

ホモ接合性家族性高コレステロール血症の日本人患者におけるロミタピド治療のための56週間の低脂肪食中の食事摂取

Author (18)： Kameyama Noriko (Department of Food and Nutrition, Faculty of Human Sciences and Design, Japan Women’s University) ,  Maruyama Chizuko (Department of Food and Nutrition, Faculty of Human Sciences and Design, Japan Women’s University) ,  Kitagawa Fuyuha (Department of Clinical Nutrition, National Cerebral and Cardiovascular Center) ,  Nishii Kazunobu (Department of Clinical Nutrition, National Cerebral and Cardiovascular Center) ,  Uenomachi Kaori (Department of Clinical Nutrition, National Cerebral and Cardiovascular Center) ,  Katayama Yayoi (Department of Nutrition, Kenporen Osaka Central Hospital) ,  Koga Hiromi (Department of Nutritional Management, Shin-Koga Clinic, Medical Group Tenjin-kai) ,  Chikamoto Naoko (Department of Nutritional Management, Shin-Koga Clinic, Medical Group Tenjin-kai) ,  Kuwata Yuko (Department of Nutrition, Tokorozawa Heart Center) ,  Torigoe Junko (Department of Clinical Nutrition, Tokyo Medical and Dental University Medical Hospital) ,  Arimoto Masako (Department of Clinical Nutrition, Tokyo Medical and Dental University Medical Hospital) ,  Tokumaru Toshiaki (Department of Nutrition Management, Kanazawa University Hospital) ,  Ikewaki Katsunori (Division of Neurology, Anti-Aging, and Vascular Medicine, Department of Internal Medicine, National Defense Medical College) ,  Nohara Atsushi (Kanazawa University Health Service Center) ,  Otsubo Yoshihiko (Department of Internal Medicine, Shin-Koga Clinic, Medical Group Tenjin-kai) ,  Yanagi Koji (Department of Cardiovascular Medicine, Kenporen Osaka Central Hospital) ,  Yoshida Masayuki (Life Science and Bioethics Research Center, Tokyo Medical and Dental University) ,  Harada-Shiba Mariko (Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute)
Material： Journal of Atherosclerosis and Thrombosis (Web)  (J Atheroscler Thromb (Web))
Volume： 26  Issue： 1  Page： 72-83(J-STAGE)  Publication year： 2019 
JST Material Number： U0153A  ISSN： 1880-3873  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： *Homozygous familial hypercholesterolaemia ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A0217253&from=J-GLOBAL&jstjournalNo=U0153A") }}

Author keywords (4)： Homozygous familial hypercholesterolemia ,  Lomitapide ,  Diet therapy ,  Low-fat diet

JST classification (2)： Treatment for congenital diseases,deformities.  (GD03030R) ,  Treatment for metabolic diseases,nutritional diseases.  (GD05030F)

Substance index (1)： BMS-201038

Reference (27)：

• 1) Cuchel M, Bruckert E, Ginsberg HN, Raal FJ, Santos RD, Hegele RA, Kuivenhoven JA, Nordestgaard BG, Descamps OS, Steinhagen-Thiessen E, Tybjaerg-Hansen A, Watts GF, Averna M, Boileau C, Borén J, Catapano AL, Defesche JC, Hovingh GK, Humphries SE, Kovanen PT, Masana L, Pajukanta P, Parhofer KG, Ray KK, Stalenhoef AF, Stroes E, Taskinen MR, Wiegman A, Wiklund O and Chapman MJ; European Atherosclerosis Society Consensus Panel on Familial Hypercholesterolaemia: Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. Eur Heart J, 2014; 35: 2146-2157
• 2) Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, Wiklund O, Hegele RA, Raal FJ, Defesche JC, Wiegman A, Santos RD, Watts GF, Parhofer KG, Hovingh GK, Kovanen PT, Boileau C, Averna M, Borén J, Bruckert E, Catapano AL, Kuivenhoven JA, Pajukanta P, Ray K, Stalenhoef AF, Stroes E, Taskinen MR and Tybjaerg-Hansen A; European Atherosclerosis Society Consensus Panel: Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J, 2013; 34: 3478-3490a
• 3) Makino H and Harada-Shiba M: Long-term effect of low-density lipoprotein apheresis in patients with homozygous familial hypercholesterolemia. Ther Apher Dial, 2003; 7: 397-401
• 4) Cuchel M, Meagher EA, du Toit Theron H, Blom DJ, Marais AD, Hegele RA, Averna MR, Sirtori CR, Shah PK, Gaudet D, Stefanutti C, Vigna GB, Du Plessis AME, Propert KJ, Sasiela WJ, Bloedon LT and Rader DJ; Phase 3 HoFH Lomitapide Study investigators: Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study. Lancet, 2013; 381: 40-46
• 5) Harada-Shiba M, Ikewaki K, Nohara A, Otsubo Y, Yanagi K, Yoshida M, Chang Q and Foulds P: Efficacy and Safety of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia. J Atheroscler Thromb, 2017; 24: 402-411

Terms in the title (7)： ホモ接合性家族性高コレステロール血症 ,  日本人 ,  患者 ,  ロミタピド ,  治療 ,  低脂肪食 ,  食事摂取